✦ LIBER ✦
204 POSTER Recombinant IL-21 in combination with sorafenib as second or third-line therapy for metastatic renal cell carcinoma (mRCC): Interim results from a Phase 2 study
✍ Scribed by T.W. Flaig; B.D. Curti; M.S. Gordon; P.J. Van Veldhuizen; W.H. Miller; M.S. Ernstoff; S. Bhatia; N.H. Hunder; N. Royer; J.A. Thompson
- Book ID
- 119599359
- Publisher
- Elsevier Science
- Year
- 2008
- Tongue
- English
- Weight
- 76 KB
- Volume
- 6
- Category
- Article
- ISSN
- 1359-6349
No coin nor oath required. For personal study only.